Evidence Partners Raises $20M for Automated, Evidence-Based Research

DistillerSR is a web-based platform that allows researchers to collaborate concurrently on the same projects from anywhere, without blocking or overwriting one another. Bootstrapped since its formation in 2008, Evidence Partners pioneered the development of AI-enabled literature review software through the development of DistillerSR, which has had double-digit growth since the platform's launch in 2009. Literature reviews are the cornerstone of evidence-based research, but their production has traditionally been highly manual, time consuming, and error prone. Today, more than 300 of the world's leading research organizations, including more than 60 percent of the largest pharmaceutical and medical device companies, trust DistillerSR to securely produce transparent, audit-ready, and regulatory compliant literature reviews faster and more accurately than any other method. With more organizations using DistillerSR to automate their systematic reviews, healthcare researchers can make more informed and time-sensitive health policy decisions, clinical practice guidelines, regulatory submissions, and deliver better overall research.